HAEMONETICS CORP Quarterly Operating Margin in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Haemonetics Corp quarterly/annual Operating Margin history and growth rate from Q1 2022 to Q3 2024.
  • Haemonetics Corp Operating Margin for the quarter ending September 28, 2024 was 12.3 %, a 9.03% decline year-over-year.
  • Haemonetics Corp annual Operating Margin for 2014 was 4.45 %, a 9.9% decline from 2013.
  • Haemonetics Corp annual Operating Margin for 2013 was 4.95 %, a 21.8% decline from 2012.
  • Haemonetics Corp annual Operating Margin for 2012 was 6.33 %, a 48.1% decline from 2011.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 12.3 -1.22 -9.03% Jun 30, 2024 Sep 28, 2024
Q2 2024 11.3 -3.36 -22.9% Mar 31, 2024 Jun 29, 2024
Q1 2024 12.6 -0.76 -5.69% Dec 31, 2023 Mar 30, 2024
Q4 2023 13.4 +1 +8.07% Oct 1, 2023 Dec 30, 2023
Q3 2023 13.5 +1.3 +10.6% Jul 2, 2023 Sep 30, 2023
Q2 2023 14.7 +3.95 +36.8% Apr 2, 2023 Jul 1, 2023
Q1 2023 13.4 +5.22 +64.2% Jan 1, 2023 Apr 1, 2023
Q4 2022 12.4 Oct 2, 2022 Dec 31, 2022
Q3 2022 12.2 Jul 3, 2022 Oct 1, 2022
Q2 2022 10.7 Apr 3, 2022 Jul 2, 2022
Q1 2022 8.13 Jan 2, 2022 Apr 2, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.